The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-11 of 11 articles
Heparin pretreatment in STEMI: is earlier always better?
October 21, 2022 | 10.4244/EIJ-E-22-00035
Antiplatelet therapy after percutaneous coronary intervention
April 1, 2022 | 10.4244/EIJ-D-21-00904
Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: a CULPRIT-SHOCK angiographic substudy
Overtchouk P,
Barthélémy O,
Hauguel-Moreau M,
Guedeney P,
Rouanet S,
Zeitouni M,
Silvain J,
Collet J,
Vicaut E,
Zeymer U,
Desch S,
Thiele H,
Montalescot G
February 5, 2021 | 10.4244/EIJ-D-20-00139
Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysis
Collet J,
Kerneis M,
Lattuca B,
Yan Y,
Cayla G,
Silvain J,
Lapostolle F,
Ecollan P,
Diallo A,
Vicaut E,
Hamm C,
van't Hof A,
Montalescot G
September 20, 2018 | 10.4244/EIJ-D-18-00182
The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction: a systematic review and meta-analysis
Bellemain-Appaix A,
Begue C,
Bhatt D,
Ducci K,
Harrington R,
Roe M,
Wiviott SD,
Cucherat M,
Silvain J,
Collet J,
Bernasconi F,
Montalescot G
May 20, 2018 | 10.4244/EIJ-D-17-00852
Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support
Overtchouk P,
Pascal J,
Lebreton G,
Hulot J-S,
Luyt C-E,
Combes A,
Kerneis M,
Silvain J,
Barthelemy O,
Leprince P,
Brechot N,
Montalescot G,
Collet J
April 6, 2018 | 10.4244/EIJ-D-17-01014
Intravenous enoxaparin anticoagulation in percutaneous left atrial cardiac procedures
Guedeney P,
Hammoudi N,
Duthoit G,
Yan Y,
Silvain J,
Pousset F,
Isnard R,
Redheuil A,
Kerneis M,
Collet J,
Montalescot G
November 20, 2017 | 10.4244/EIJ-D-17-00518
Antithrombotic therapy in TAVI patients: changing concepts
September 17, 2015 | 10.4244/EIJV11SWA28
Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement
Capodanno D,
Lip G,
Windecker S,
Huber K,
Kirchhof P,
Boriani G,
Lane D,
Gilard M,
Collet J,
Valgimigli M,
Byrne R
January 22, 2015 | 10.4244/EIJV10I9A174
2014 ESC/EACTS Guidelines on myocardial revascularization
Windecker S,
Kolh P,
Alfonso F,
Collet J,
Cremer J,
Falk V,
Filippatos G,
Hamm C,
Head S,
Jüni P,
Kappetein AP,
Kastrati A,
Knuuti J,
Landmesser U,
Laufer G,
Neumann F,
Richter D,
Schauerte P,
Uva M,
Stefanini G,
Taggart D,
Torracca L,
Valgimigli M,
Wijns W,
Witkowski A
January 22, 2015 | 10.4244/EIJY14M09_01
Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field?
September 15, 2013 | 10.4244/EIJV9SSA9
Latest news
AHEAD OF PRINT
Outcomes of DES by degree of coronary calcification: a pooled analysis of the ISAR-TEST 4 and 5 randomised trials
FREE ARTICLE - Tobias Rheude et al
December 1, 2022
AHEAD OF PRINT
Early pathologic responses to BP- vs DP-DES
FREE ARTICLE - Yasuhito Kawagoe et al
November 30, 2022
NEW ISSUE
PCR London Valves issue; debates on key issues; unplanned PCI after TAVR; percutaneous vascular closure strategies after TAVI; ViV-TMVR vs redo-SMVR; RV-PA coupling on TR after TEER...
November 18, 2022
AHEAD OF PRINT
Continued NOAC vs VKA in TAVI
FREE ARTICLE - Norman Mangner et al
November 28, 2022
PCR LONDON VALVES LATE BREAKING
ACURATE neo2 PMCF Study
FREE ARTICLE - Won-Keun Kim et al
November 27, 2022
AHEAD OF PRINT
TAVI with a novel system for severe pure native AR in a patient with ascending aorta aneurysm
FREE ARTICLE - Hendrik Wienemann et al
November 23, 2022
AHEAD OF PRINT
Radiation protection for pregnant healthcare professionals: an EAPCI statement
FREE ARTICLE - Stéphane Manzo-Silberman et al
November 22, 2022